BioNexus Gene Lab (BGLC) Competitors $5.04 -0.65 (-11.42%) Closing price 09/5/2025 04:00 PM EasternExtended Trading$5.20 +0.16 (+3.08%) As of 09/5/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BGLC vs. BMGL, KDLY, MGRX, MRAI, CCM, BRTX, SSY, ACON, DHAC, and NIVFShould you be buying BioNexus Gene Lab stock or one of its competitors? The main competitors of BioNexus Gene Lab include Basel Medical Group (BMGL), Kindly MD (KDLY), Mangoceuticals (MGRX), Marpai (MRAI), Concord Medical Services (CCM), Biorestorative Therapies (BRTX), SunLink Health Systems (SSY), Aclarion (ACON), Digital Health Acquisition (DHAC), and NewGenIvf Group (NIVF). These companies are all part of the "healthcare" industry. BioNexus Gene Lab vs. Its Competitors Basel Medical Group Kindly MD Mangoceuticals Marpai Concord Medical Services Biorestorative Therapies SunLink Health Systems Aclarion Digital Health Acquisition NewGenIvf Group Basel Medical Group (NASDAQ:BMGL) and BioNexus Gene Lab (NASDAQ:BGLC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Which has higher earnings & valuation, BMGL or BGLC? Basel Medical Group has higher earnings, but lower revenue than BioNexus Gene Lab. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/ABioNexus Gene Lab$9.55M0.95-$1.60MN/AN/A Is BMGL or BGLC more profitable? Basel Medical Group has a net margin of 0.00% compared to BioNexus Gene Lab's net margin of -30.70%. Basel Medical Group's return on equity of 0.00% beat BioNexus Gene Lab's return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A BioNexus Gene Lab -30.70%-35.54%-29.08% Does the media prefer BMGL or BGLC? In the previous week, BioNexus Gene Lab had 2 more articles in the media than Basel Medical Group. MarketBeat recorded 2 mentions for BioNexus Gene Lab and 0 mentions for Basel Medical Group. BioNexus Gene Lab's average media sentiment score of 0.99 beat Basel Medical Group's score of 0.00 indicating that BioNexus Gene Lab is being referred to more favorably in the news media. Company Overall Sentiment Basel Medical Group Neutral BioNexus Gene Lab Positive Do insiders & institutionals believe in BMGL or BGLC? 18.9% of BioNexus Gene Lab shares are held by institutional investors. 0.7% of BioNexus Gene Lab shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryBioNexus Gene Lab beats Basel Medical Group on 5 of the 8 factors compared between the two stocks. Get BioNexus Gene Lab News Delivered to You Automatically Sign up to receive the latest news and ratings for BGLC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BGLC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BGLC vs. The Competition Export to ExcelMetricBioNexus Gene LabMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.06M$7.63B$5.83B$9.91BDividend YieldN/A2.83%6.70%4.52%P/E RatioN/A77.2876.2926.13Price / Sales0.9541.86532.56172.96Price / CashN/A23.8936.9959.28Price / Book1.097.4211.486.09Net Income-$1.60M$238.91M$3.29B$266.51M7 Day Performance-11.27%-0.74%1.28%0.45%1 Month Performance-10.95%3.64%8.56%5.05%1 Year Performance22.96%11.82%61.19%26.03% BioNexus Gene Lab Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BGLCBioNexus Gene Lab0.7359 of 5 stars$5.04-11.4%N/A+23.0%$9.06M$9.55M0.0030Short Interest ↓Gap DownBMGLBasel Medical GroupN/A$2.00-2.0%N/AN/A$37.65MN/A0.0036Positive NewsKDLYKindly MDN/A$5.44-8.3%N/A+205.6%$32.76M$2.47M-7.06N/AGap UpMGRXMangoceuticals1.7782 of 5 stars$2.24-5.1%N/A-96.3%$24.86M$620K-0.583News CoverageShort Interest ↓MRAIMarpaiN/A$1.38-2.1%N/A+94.2%$24.35M$34.87M-0.52150CCMConcord Medical Services0.4798 of 5 stars$5.24+0.3%N/A-9.5%$22.68M$52.60M0.00970Negative NewsShort Interest ↑BRTXBiorestorative Therapies1.2549 of 5 stars$1.73-6.0%N/A+4.6%$14.68M$400K-1.367SSYSunLink Health SystemsN/A$1.12+16.6%N/A+46.5%$7.88M$31.09M4.661,376Gap UpACONAclarion2.4127 of 5 stars$7.15-0.3%$11,758.50+164,354.5%-99.6%$4.17M$50K0.007Gap DownDHACDigital Health AcquisitionN/A$0.60-22.1%N/A-53.1%$2.16MN/A0.002,021News CoverageGap DownHigh Trading VolumeNIVFNewGenIvf GroupN/A$1.99+5.9%N/A-99.7%$1.63M$5.43M0.00N/AShort Interest ↓ Related Companies and Tools Related Companies BMGL Alternatives KDLY Alternatives MGRX Alternatives MRAI Alternatives CCM Alternatives BRTX Alternatives SSY Alternatives ACON Alternatives DHAC Alternatives NIVF Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BGLC) was last updated on 9/7/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNexus Gene Lab Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNexus Gene Lab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
